$BRL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BARR PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BARR PHARMACEUTICALS INC. Get notifications about new insider transactions in BARR PHARMACEUTICALS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 15 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 20 2006 | BRL | BARR PHARMACEUTICA ... | Wilkinson George Fred | President & COO | Option Exercise | A | 66.54 | 1,502 | 99,943 | 1,502 | |
Mar 20 2006 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Director | Gift | G | 61.57 | 5,000 | 307,850 | 48,639 | 53.6 K to 48.6 K (-9.32 %) |
Mar 06 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Option Exercise | X | 26.58 | 17,800 | 473,163 | 236,220 | |
Mar 06 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Sell | S | 67.00 | 17,800 | 1,192,600 | 14,321 | 32.1 K to 14.3 K (-55.42 %) |
Mar 06 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Buy | X | 26.58 | 17,800 | 473,163 | 32,121 | 14.3 K to 32.1 K (+124.29 %) |
Mar 02 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Option Exercise | X | 26.58 | 7,200 | 191,392 | 254,020 | |
Mar 02 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Option Exercise | X | 28.89 | 15,000 | 433,334 | 261,220 | |
Mar 02 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Sell | S | 66.88 | 22,200 | 1,484,780 | 14,321 | 36.5 K to 14.3 K (-60.79 %) |
Mar 02 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Buy | X | 26.58 | 7,200 | 191,392 | 36,521 | 29.3 K to 36.5 K (+24.56 %) |
Mar 02 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Buy | X | 28.89 | 15,000 | 433,334 | 29,321 | 14.3 K to 29.3 K (+104.74 %) |
Feb 14 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Option Exercise | X | 36.33 | 25,700 | 933,653 | 280,520 | |
Feb 14 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Sell | S | 67.00 | 25,700 | 1,721,900 | 14,321 | 40 K to 14.3 K (-64.22 %) |
Feb 14 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Buy | X | 36.33 | 25,700 | 933,653 | 40,021 | 14.3 K to 40 K (+179.46 %) |
Mar 02 2006 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | X | 11.75 | 2,737 | 32,163 | 675,492 | |
Mar 02 2006 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | X | 11.75 | 11,250 | 132,200 | 678,229 | |
Mar 02 2006 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | X | 11.75 | 1,253 | 14,724 | 689,479 | |
Mar 02 2006 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Sell | S | 66.83 | 15,240 | 1,018,474 | 105,767 | 121 K to 105.8 K (-12.59 %) |
Mar 02 2006 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Buy | X | 11.75 | 15,240 | 179,087 | 121,007 | 105.8 K to 121 K (+14.41 %) |
Feb 23 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Option Exercise | X | 36.33 | 4,300 | 156,214 | 276,220 | |
Feb 23 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Sell | S | 67.00 | 4,300 | 288,100 | 14,321 | 18.6 K to 14.3 K (-23.09 %) |
Feb 23 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Buy | X | 36.33 | 4,300 | 156,214 | 18,621 | 14.3 K to 18.6 K (+30.03 %) |
Feb 14 2006 | BRL | BARR PHARMACEUTICA ... | KILLION FREDERICK | General Counsel | Option Exercise | X | 30.19 | 1,624 | 49,023 | 177,500 | |
Feb 14 2006 | BRL | BARR PHARMACEUTICA ... | KILLION FREDERICK | General Counsel | Option Exercise | X | 30.19 | 19,188 | 579,222 | 179,124 | |
Feb 14 2006 | BRL | BARR PHARMACEUTICA ... | KILLION FREDERICK | General Counsel | Option Exercise | X | 30.19 | 19,188 | 579,222 | 198,312 | |
Feb 14 2006 | BRL | BARR PHARMACEUTICA ... | KILLION FREDERICK | General Counsel | Sell | S | 66.27 | 40,000 | 2,650,604 | 1,590 | 41.6 K to 1.6 K (-96.18 %) |
Feb 14 2006 | BRL | BARR PHARMACEUTICA ... | KILLION FREDERICK | General Counsel | Buy | X | 30.19 | 40,000 | 1,207,468 | 41,590 | 1.6 K to 41.6 K (+2,515.72 %) |
Feb 09 2006 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Director | Option Exercise | X | 5.11 | 5,000 | 25,556 | 167,186 | |
Feb 09 2006 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Director | Sell | S | 68.49 | 5,000 | 342,459 | 53,639 | 58.6 K to 53.6 K (-8.53 %) |
Feb 09 2006 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Director | Buy | X | 5.11 | 5,000 | 25,556 | 58,639 | 53.6 K to 58.6 K (+9.32 %) |
Feb 13 2006 | BRL | BARR PHARMACEUTICA ... | MCKEE WILLIAM | Sr.VP, CFO & Treasu ... | Option Exercise | X | 26.58 | 18,520 | 492,302 | 199,749 | |
Feb 13 2006 | BRL | BARR PHARMACEUTICA ... | MCKEE WILLIAM | Sr.VP, CFO & Treasu ... | Option Exercise | X | 26.58 | 23,240 | 617,770 | 218,269 | |
Feb 13 2006 | BRL | BARR PHARMACEUTICA ... | MCKEE WILLIAM | Sr.VP, CFO & Treasu ... | Option Exercise | X | 26.58 | 3,240 | 86,126 | 241,509 | |
Feb 13 2006 | BRL | BARR PHARMACEUTICA ... | MCKEE WILLIAM | Sr.VP, CFO & Treasu ... | Sell | S | 68.63 | 45,000 | 3,088,233 | 11,577 | 56.6 K to 11.6 K (-79.54 %) |
Feb 13 2006 | BRL | BARR PHARMACEUTICA ... | MCKEE WILLIAM | Sr.VP, CFO & Treasu ... | Buy | X | 26.58 | 45,000 | 1,196,199 | 56,577 | 11.6 K to 56.6 K (+388.70 %) |
Feb 07 2006 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Director | Gift | G | 67.50 | 1,000 | 67,500 | 53,639 | 54.6 K to 53.6 K (-1.83 %) |
Feb 02 2006 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Director | Gift | G | 64.98 | 1,000 | 64,980 | 59,639 | 60.6 K to 59.6 K (-1.65 %) |
Feb 02 2006 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Director | Gift | G | 64.98 | 1,000 | 64,980 | 60,639 | 61.6 K to 60.6 K (-1.62 %) |
Feb 06 2006 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Director | Gift | G | 66.98 | 5,000 | 334,900 | 54,639 | 59.6 K to 54.6 K (-8.38 %) |
Feb 01 2006 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | X | 11.75 | 10,000 | 117,511 | 690,732 | |
Feb 01 2006 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Sell | S | 66.23 | 10,000 | 662,310 | 105,767 | 115.8 K to 105.8 K (-8.64 %) |
Feb 01 2006 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Buy | X | 11.75 | 10,000 | 117,511 | 115,767 | 105.8 K to 115.8 K (+9.45 %) |
Feb 01 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Option Exercise | X | 28.89 | 7,500 | 216,667 | 306,220 | |
Feb 01 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Option Exercise | X | 18.22 | 12,500 | 227,778 | 313,720 | |
Feb 01 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Sell | S | 66.08 | 20,000 | 1,321,640 | 14,321 | 34.3 K to 14.3 K (-58.27 %) |
Feb 01 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Buy | X | 28.89 | 7,500 | 216,667 | 34,321 | 26.8 K to 34.3 K (+27.96 %) |
Feb 01 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Buy | X | 18.22 | 12,500 | 227,778 | 26,821 | 14.3 K to 26.8 K (+87.28 %) |
Jan 09 2006 | BRL | BARR PHARMACEUTICA ... | Donaghy Suzanne | Sr Vice President/C ... | Option Exercise | X | 35.01 | 5,000 | 175,050 | 74,498 | |
Jan 09 2006 | BRL | BARR PHARMACEUTICA ... | Donaghy Suzanne | Sr Vice President/C ... | Option Exercise | X | 24.56 | 3,750 | 92,117 | 79,498 | |
Jan 09 2006 | BRL | BARR PHARMACEUTICA ... | Donaghy Suzanne | Sr Vice President/C ... | Option Exercise | X | 11.06 | 3,943 | 43,618 | 83,248 | |
Jan 09 2006 | BRL | BARR PHARMACEUTICA ... | Donaghy Suzanne | Sr Vice President/C ... | Option Exercise | X | 10.05 | 5,620 | 56,475 | 87,191 | |
Jan 09 2006 | BRL | BARR PHARMACEUTICA ... | Donaghy Suzanne | Sr Vice President/C ... | Option Exercise | X | 10.05 | 5,626 | 56,535 | 92,811 | |
Jan 09 2006 | BRL | BARR PHARMACEUTICA ... | Donaghy Suzanne | Sr Vice President/C ... | Option Exercise | X | 10.05 | 4,922 | 49,461 | 98,437 | |
Jan 09 2006 | BRL | BARR PHARMACEUTICA ... | Donaghy Suzanne | Sr Vice President/C ... | Sell | S | 64.35 | 28,861 | 1,857,194 | 5,678 | 34.5 K to 5.7 K (-83.56 %) |
Jan 09 2006 | BRL | BARR PHARMACEUTICA ... | Donaghy Suzanne | Sr Vice President/C ... | Buy | X | 35.01 | 5,000 | 175,050 | 34,539 | 29.5 K to 34.5 K (+16.93 %) |
Jan 09 2006 | BRL | BARR PHARMACEUTICA ... | Donaghy Suzanne | Sr Vice President/C ... | Buy | X | 24.56 | 3,750 | 92,117 | 29,539 | 25.8 K to 29.5 K (+14.54 %) |
Jan 09 2006 | BRL | BARR PHARMACEUTICA ... | Donaghy Suzanne | Sr Vice President/C ... | Buy | X | 11.06 | 3,943 | 43,618 | 25,789 | 21.8 K to 25.8 K (+18.05 %) |
Jan 09 2006 | BRL | BARR PHARMACEUTICA ... | Donaghy Suzanne | Sr Vice President/C ... | Buy | X | 10.05 | 16,168 | 162,471 | 21,846 | 5.7 K to 21.8 K (+284.75 %) |
Feb 01 2006 | BRL | BARR PHARMACEUTICA ... | MCKEE WILLIAM | Sr.VP, CFO & Treasu ... | Option Exercise | X | 10.05 | 3,449 | 34,659 | 244,747 | |
Feb 01 2006 | BRL | BARR PHARMACEUTICA ... | MCKEE WILLIAM | Sr.VP, CFO & Treasu ... | Buy | X | 10.05 | 3,449 | 34,659 | 11,577 | 8.1 K to 11.6 K (+42.43 %) |
Jan 10 2006 | BRL | BARR PHARMACEUTICA ... | AMED SALAH | Sr.VP, R&D | Option Exercise | X | 11.06 | 45,800 | 506,649 | 267,473 | |
Jan 10 2006 | BRL | BARR PHARMACEUTICA ... | AMED SALAH | Sr.VP, R&D | Option Exercise | X | 11.06 | 4,804 | 53,143 | 313,273 | |
Jan 10 2006 | BRL | BARR PHARMACEUTICA ... | AMED SALAH | Sr.VP, R&D | Sell | S | 66.62 | 45,800 | 3,051,301 | 135,437 | 181.2 K to 135.4 K (-25.27 %) |
Jan 10 2006 | BRL | BARR PHARMACEUTICA ... | AMED SALAH | Sr.VP, R&D | Buy | X | 11.06 | 45,800 | 506,649 | 181,237 | 135.4 K to 181.2 K (+33.82 %) |
Jan 10 2006 | BRL | BARR PHARMACEUTICA ... | AMED SALAH | Sr.VP, R&D | Sell | S | 66.54 | 4,804 | 319,635 | 135,437 | 140.2 K to 135.4 K (-3.43 %) |
Jan 10 2006 | BRL | BARR PHARMACEUTICA ... | AMED SALAH | Sr.VP, R&D | Buy | X | 11.06 | 4,804 | 53,143 | 140,241 | 135.4 K to 140.2 K (+3.55 %) |
Jan 06 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Option Exercise | X | 32.84 | 41,953 | 1,377,548 | 326,220 | |
Jan 06 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Sell | S | 64.26 | 41,953 | 2,696,080 | 14,321 | 56.3 K to 14.3 K (-74.55 %) |
Jan 06 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Buy | X | 32.84 | 41,953 | 1,377,548 | 56,274 | 14.3 K to 56.3 K (+292.95 %) |
Jan 05 2006 | BRL | BARR PHARMACEUTICA ... | AMED SALAH | Sr.VP, R&D | Option Exercise | X | 10.05 | 6,925 | 69,589 | 318,077 | |
Jan 05 2006 | BRL | BARR PHARMACEUTICA ... | AMED SALAH | Sr.VP, R&D | Option Exercise | X | 10.05 | 16,875 | 169,575 | 325,002 | |
Jan 05 2006 | BRL | BARR PHARMACEUTICA ... | AMED SALAH | Sr.VP, R&D | Option Exercise | X | 11.75 | 2,737 | 32,163 | 341,877 | |
Jan 05 2006 | BRL | BARR PHARMACEUTICA ... | AMED SALAH | Sr.VP, R&D | Option Exercise | X | 5.72 | 17,489 | 99,958 | 344,614 | |
Jan 05 2006 | BRL | BARR PHARMACEUTICA ... | AMED SALAH | Sr.VP, R&D | Option Exercise | X | 5.72 | 17,489 | 99,958 | 362,103 | |
Jan 05 2006 | BRL | BARR PHARMACEUTICA ... | AMED SALAH | Sr.VP, R&D | Sell | S | 63.25 | 26,537 | 1,678,468 | 135,437 | 162 K to 135.4 K (-16.38 %) |
Jan 05 2006 | BRL | BARR PHARMACEUTICA ... | AMED SALAH | Sr.VP, R&D | Buy | X | 10.05 | 23,800 | 239,164 | 161,974 | 138.2 K to 162 K (+17.22 %) |
Jan 05 2006 | BRL | BARR PHARMACEUTICA ... | AMED SALAH | Sr.VP, R&D | Buy | X | 11.75 | 2,737 | 32,163 | 138,174 | 135.4 K to 138.2 K (+2.02 %) |
Jan 05 2006 | BRL | BARR PHARMACEUTICA ... | AMED SALAH | Sr.VP, R&D | Buy | X | 5.71 | 34,978 | 199,777 | 135,437 | 100.5 K to 135.4 K (+34.82 %) |
Jan 04 2006 | BRL | BARR PHARMACEUTICA ... | MCKEE WILLIAM | Sr.VP, CFO & Treasu ... | Option Exercise | X | 10.05 | 3,500 | 35,171 | 248,198 | |
Jan 04 2006 | BRL | BARR PHARMACEUTICA ... | MCKEE WILLIAM | Sr.VP, CFO & Treasu ... | Option Exercise | X | 24.56 | 22,500 | 552,701 | 251,698 | |
Jan 04 2006 | BRL | BARR PHARMACEUTICA ... | MCKEE WILLIAM | Sr.VP, CFO & Treasu ... | Sell | S | 61.85 | 26,000 | 1,608,105 | 8,128 | 34.1 K to 8.1 K (-76.18 %) |
Jan 04 2006 | BRL | BARR PHARMACEUTICA ... | MCKEE WILLIAM | Sr.VP, CFO & Treasu ... | Buy | X | 10.05 | 3,500 | 35,171 | 34,128 | 30.6 K to 34.1 K (+11.43 %) |
Jan 04 2006 | BRL | BARR PHARMACEUTICA ... | MCKEE WILLIAM | Sr.VP, CFO & Treasu ... | Buy | X | 24.56 | 22,500 | 552,701 | 30,628 | 8.1 K to 30.6 K (+276.82 %) |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | X | 11.75 | 8,506 | 99,955 | 700,732 | |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | X | 5.72 | 17,489 | 99,958 | 709,238 | |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | X | 5.72 | 17,489 | 99,958 | 726,727 | |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Buy | S | 61.63 | 10,000 | 616,320 | 105,767 | 95.8 K to 105.8 K (+10.44 %) |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Buy | X | 11.75 | 8,506 | 99,955 | 115,767 | 107.3 K to 115.8 K (+7.93 %) |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Buy | X | 5.72 | 34,978 | 199,917 | 107,261 | 72.3 K to 107.3 K (+48.39 %) |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | Mengler Christopher | Sr. VP | Option Exercise | X | 35.01 | 750 | 26,258 | 77,399 | |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | Mengler Christopher | Sr. VP | Option Exercise | X | 43.34 | 900 | 39,006 | 78,149 | |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | Mengler Christopher | Sr. VP | Option Exercise | X | 30.39 | 1,350 | 41,028 | 79,049 | |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | Mengler Christopher | Sr. VP | Sell | S | 61.63 | 3,000 | 184,896 | 484 | 3.5 K to 484 (-86.11 %) |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | Mengler Christopher | Sr. VP | Buy | X | 35.01 | 750 | 26,258 | 3,484 | 2.7 K to 3.5 K (+27.43 %) |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | Mengler Christopher | Sr. VP | Buy | X | 43.34 | 900 | 39,006 | 2,734 | 1.8 K to 2.7 K (+49.07 %) |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | Mengler Christopher | Sr. VP | Buy | X | 30.39 | 1,350 | 41,028 | 1,834 | 484 to 1.8 K (+278.93 %) |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Option Exercise | X | 43.34 | 9,998 | 433,313 | 368,173 | |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Option Exercise | X | 18.22 | 10,000 | 182,222 | 378,171 | |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Sell | S | 61.63 | 19,998 | 1,232,517 | 14,321 | 34.3 K to 14.3 K (-58.27 %) |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Buy | X | 43.34 | 9,998 | 433,313 | 34,319 | 24.3 K to 34.3 K (+41.11 %) |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | BEN MAIMON CAROL | President & COO Bar ... | Buy | X | 18.22 | 10,000 | 182,222 | 24,321 | 14.3 K to 24.3 K (+69.83 %) |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | CHEFITZ HAROLD N | Director | Option Exercise | X | 29.11 | 1,000 | 29,111 | 62,500 | |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | CHEFITZ HAROLD N | Director | Sell | S | 62.29 | 1,000 | 62,290 | 5,250 | 6.3 K to 5.3 K (-16.00 %) |
Jan 03 2006 | BRL | BARR PHARMACEUTICA ... | CHEFITZ HAROLD N | Director | Buy | X | 29.11 | 1,000 | 29,111 | 6,250 | 5.3 K to 6.3 K (+19.05 %) |
Dec 27 2005 | BRL | BARR PHARMACEUTICA ... | MUNDKUR CHRISTINE | Sr.VP, Quality and ... | Option Exercise | X | 11.75 | 4,500 | 52,880 | 175,553 | |
Dec 27 2005 | BRL | BARR PHARMACEUTICA ... | MUNDKUR CHRISTINE | Sr.VP, Quality and ... | Option Exercise | X | 11.75 | 4,500 | 52,880 | 180,053 | |
Dec 27 2005 | BRL | BARR PHARMACEUTICA ... | MUNDKUR CHRISTINE | Sr.VP, Quality and ... | Option Exercise | X | 11.75 | 4,500 | 52,880 | 184,553 | |
Dec 27 2005 | BRL | BARR PHARMACEUTICA ... | MUNDKUR CHRISTINE | Sr.VP, Quality and ... | Option Exercise | X | 5.72 | 4,213 | 24,079 | 189,053 | |
Dec 27 2005 | BRL | BARR PHARMACEUTICA ... | MUNDKUR CHRISTINE | Sr.VP, Quality and ... | Option Exercise | X | 5.72 | 4,213 | 24,079 | 193,266 | |
Dec 27 2005 | BRL | BARR PHARMACEUTICA ... | MUNDKUR CHRISTINE | Sr.VP, Quality and ... | Option Exercise | X | 5.72 | 4,225 | 24,148 | 197,479 | |
Dec 27 2005 | BRL | BARR PHARMACEUTICA ... | MUNDKUR CHRISTINE | Sr.VP, Quality and ... | Buy | X | 11.75 | 13,500 | 158,640 | 27,976 | 14.5 K to 28 K (+93.26 %) |
Dec 27 2005 | BRL | BARR PHARMACEUTICA ... | MUNDKUR CHRISTINE | Sr.VP, Quality and ... | Buy | X | 5.72 | 12,651 | 72,307 | 14,476 | 1.8 K to 14.5 K (+693.21 %) |
Dec 21 2005 | BRL | BARR PHARMACEUTICA ... | HIGGINS CATHERINE | Sr.VP, Human Resour ... | Option Exercise | X | 11.75 | 7,000 | 82,258 | 224,472 | |
Dec 21 2005 | BRL | BARR PHARMACEUTICA ... | HIGGINS CATHERINE | Sr.VP, Human Resour ... | Sell | S | 61.12 | 19,978 | 1,221,081 | 25,101 | 45.1 K to 25.1 K (-44.32 %) |
Dec 21 2005 | BRL | BARR PHARMACEUTICA ... | HIGGINS CATHERINE | Sr.VP, Human Resour ... | Buy | X | 11.75 | 7,000 | 82,258 | 45,079 | 38.1 K to 45.1 K (+18.38 %) |
Dec 15 2005 | BRL | BARR PHARMACEUTICA ... | CATLETT TIMOTHY | Sr.VP, Sales & Mark ... | Option Exercise | X | 26.58 | 12,719 | 338,099 | 58,004 | |
Dec 15 2005 | BRL | BARR PHARMACEUTICA ... | CATLETT TIMOTHY | Sr.VP, Sales & Mark ... | Sell | S | 59.68 | 12,719 | 759,113 | 2 | 12.7 K to 2 (-99.98 %) |
Dec 15 2005 | BRL | BARR PHARMACEUTICA ... | CATLETT TIMOTHY | Sr.VP, Sales & Mark ... | Buy | X | 26.58 | 12,719 | 338,099 | 12,721 | 2 to 12.7 K (+635,950.00 %) |
Dec 14 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Option Exercise | X | 10.05 | 21,145 | 212,484 | 1,133,696 | |
Dec 14 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Sell | S | 59.47 | 21,145 | 1,257,519 | 423,655 | 444.8 K to 423.7 K (-4.75 %) |
Dec 14 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Buy | X | 10.05 | 21,145 | 212,484 | 444,800 | 423.7 K to 444.8 K (+4.99 %) |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Option Exercise | X | 10.05 | 13,902 | 139,700 | 1,154,841 | |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Option Exercise | X | 10.05 | 44,997 | 452,170 | 1,168,743 | |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Option Exercise | X | 10.05 | 45,006 | 452,261 | 1,213,740 | |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Option Exercise | X | 11.75 | 36,487 | 428,762 | 1,258,746 | |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Option Exercise | X | 11.75 | 45,000 | 528,800 | 1,295,233 | |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Option Exercise | X | 11.75 | 45,003 | 528,835 | 1,340,233 | |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Option Exercise | X | 5.72 | 50,005 | 285,804 | 1,385,236 | |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Option Exercise | X | 5.72 | 67,495 | 385,768 | 1,435,241 | |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Option Exercise | X | 5.72 | 67,505 | 385,825 | 1,502,736 | |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Option Exercise | X | 26.58 | 3,759 | 99,922 | 1,570,241 | |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Option Exercise | X | 26.58 | 3,759 | 99,922 | 1,574,000 | |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Option Exercise | X | 43.34 | 2 | 87 | 1,577,759 | |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Option Exercise | X | 11.06 | 19 | 210 | 1,577,761 | |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Sell | S | 59.73 | 103,905 | 6,206,235 | 423,655 | 527.6 K to 423.7 K (-19.70 %) |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Buy | X | 10.05 | 103,905 | 1,044,131 | 527,560 | 423.7 K to 527.6 K (+24.53 %) |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Sell | S | 59.73 | 126,490 | 7,555,235 | 423,655 | 550.1 K to 423.7 K (-22.99 %) |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Buy | X | 11.75 | 126,490 | 1,486,397 | 550,145 | 423.7 K to 550.1 K (+29.86 %) |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Sell | S | 59.73 | 185,005 | 11,050,330 | 423,655 | 608.7 K to 423.7 K (-30.40 %) |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Buy | X | 5.72 | 185,005 | 1,057,396 | 608,660 | 423.7 K to 608.7 K (+43.67 %) |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Buy | X | 26.58 | 7,518 | 199,845 | 423,655 | 416.1 K to 423.7 K (+1.81 %) |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Buy | X | 43.34 | 2 | 87 | 416,137 | 416.1 K to 416.1 K (0.00 %) |
Dec 13 2005 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Buy | X | 11.06 | 19 | 210 | 416,135 | 416.1 K to 416.1 K (0.00 %) |
Dec 02 2005 | BRL | BARR PHARMACEUTICA ... | CATLETT TIMOTHY | Sr.VP, Sales & Mark ... | Option Exercise | X | 26.58 | 1,521 | 40,432 | 70,723 | |
Dec 02 2005 | BRL | BARR PHARMACEUTICA ... | CATLETT TIMOTHY | Sr.VP, Sales & Mark ... | Option Exercise | X | 26.58 | 14,240 | 378,531 | 72,244 | |
Dec 02 2005 | BRL | BARR PHARMACEUTICA ... | CATLETT TIMOTHY | Sr.VP, Sales & Mark ... | Option Exercise | X | 26.58 | 4,239 | 112,682 | 86,484 | |
Dec 02 2005 | BRL | BARR PHARMACEUTICA ... | CATLETT TIMOTHY | Sr.VP, Sales & Mark ... | Sell | S | 57.23 | 20,000 | 1,144,514 | 2 | 20 K to 2 (-99.99 %) |
Dec 02 2005 | BRL | BARR PHARMACEUTICA ... | CATLETT TIMOTHY | Sr.VP, Sales & Mark ... | Buy | X | 26.58 | 20,000 | 531,644 | 20,002 | 2 to 20 K (+1,000,000.00 %) |
Dec 02 2005 | BRL | BARR PHARMACEUTICA ... | CHEFITZ HAROLD N | Director | Option Exercise | X | 29.11 | 2,000 | 58,222 | 63,500 | |
Dec 02 2005 | BRL | BARR PHARMACEUTICA ... | CHEFITZ HAROLD N | Director | Sell | S | 57.50 | 2,000 | 115,000 | 5,250 | 7.3 K to 5.3 K (-27.59 %) |
Dec 02 2005 | BRL | BARR PHARMACEUTICA ... | CHEFITZ HAROLD N | Director | Buy | X | 29.11 | 2,000 | 58,222 | 7,250 | 5.3 K to 7.3 K (+38.10 %) |